Skip to content

Aging-related memory impairment: a behavior-genomics study

Aging-related memory impairment: a behavior-genomics study - Memory genomics

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43432
Enrollment
220
Registered
2016-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No disorder: Age-related memory performance

Interventions

None listed

Sponsors

Takeda
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The subject has to sign and date a written informed consent form prior to the initiation of study procedures; 2. The subject falls in the age-range of one the cohorts, i.e. 18-30; 40-60; 60-80; 3. The subject has good comprehension of the Dutch language 4. Normal memory performance

Exclusion criteria

Exclusion criteria: - Suffering from uncontrolled, clinically significant neurologic disease or other abnormality which may impact the ability of the subject to participate or potentially confound the study results, which includes pregnancy and having received chemo treatment during the past year. - The presence of psychiatric illness including schizophrenia, depression, bipolar disorder, Attention Deficit Hyperactivity Disorder and autism; - Smoking more than 10 cigarettes a day. - Excessive drinking, i.e. >20 glasses of alcohol containing beverages a week, - Current use of psychoactive medication (e.g. antidepressants, antipsychotics), centrally acting beta blockers, use of recreational drugs from 2 weeks before until the end of the yearly testing , - Any sensory or motor deficits which could reasonably be expected to affect test performance. - Consultation of a clinical expert for memory problems before having entered the study - Having received any investigational compound within 60 days prior to the Baseline (Screening) Visit

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is memory decline in the Verbal Learning Test (VLT).

Secondary

MeasureTime frame
In the eldest group, the Mini Mental State Examination will provide a more global indication on cognitive functioning. For all groups, functioning in related cognitive domains will be assessed using the Visual Association Test, Digit Span, Fluency, Letter Digit Substitution, Stroop, Trail Making Test, and Pattern Separation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)